IZERVAY Produces Positive Results in GATHER1 and GATHER2 Studies
Join Drs. Singh and Chang to review recent findings from a post-hoc analysis of the GATHER studies on functional outcomes in patients receiving IZERVAY.
New Content
Pharmaceuticals
Reducing Treatment Burden in nAMD and DME With Tyrosine Kinase Inhibitors
May 15, 2026
Diagnostics & Imaging
Utilizing Multimodal Retinal Imaging and AI to Identify Neurocognitive Disease
May 5, 2026
Evidence Based Retina
Recently Published
CASE REPORTS
Uveal Effusion Syndrome: A Case Report from Caroline Awh, MD
Sit down with Rishi P. Singh, MD, FASRS, and Caroline Awh, MD, as they discuss a case of uveal effusion syndrome (UES).
Rishi P. Singh, MD, FASRS, Caroline Awh, MDApril 21, 2026
CLINICAL STUDIES & TRIALS
Real-World Use of Aflibercept 8mg in Eyes With nAMD or DME: Analysis of the IRIS Registry
Join Rishi P. Singh, MD, FASRS and Diana Do, MD, to discuss data from a recent study of the IRIS Registry on real-world use of aflibercept 8mg.
Rishi P. Singh, MD, FASRS, Diana Do, MDApril 14, 2026
PRODUCTS & TECHNOLOGY
The Role of SING IMT in the AMD Treatment Paradigm
Join Drs. Singh and Chin Yee to discuss advances in SING IMT technology for advanced AMD, with updates and data from ongoing clinical trials.
Rishi P. Singh, MD, FASRS, David Chin Yee, MDApril 9, 2026
CLINICAL STUDIES & TRIALS
Rates and Risk Factors for Submacular Hemorrhage in nAMD Following Anti-VEGF Injections
Rishi P. Singh, MD, FASRS, Matthew Starr, MDApril 6, 2026
PRODUCTS & TECHNOLOGY
Unlocking the Potential of Suprachoroidal Space
Rishi P. Singh, MD, FASRS, Danny A. Mammo, MDMarch 31, 2026
PRODUCTS & TECHNOLOGY
Photobiomodulation for Retinal Diseases
Rishi P. Singh, MD, FASRS, Grace Baldwin, MDMarch 26, 2026